Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03604861 · ClinicalTrials.gov registry record
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
A clinical trial of Opioid Use Disorder and Opioid-Related Disorders, sponsored by Indivior.
- Completed
- Registry status
- 534
- Enrollment target
- 20
- Study locations
NCT03604861: Completed study of Opioid Use Disorder and Opioid-Related Disorders, sponsored by Indivior.
NCT03604861 is a study of Opioid Use Disorder and Opioid-Related Disorders that has completed, run by Indivior. The registered enrollment target is 534 participants, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (89% lower). The trial reports 20 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03604861, a study of Opioid Use Disorder and Opioid-Related Disorders, has completed, sponsored by Indivior.
- COMPLETED
- Registry status
- 534 participants
- Enrollment target
- 20
- Study locations
Study Summary
The RECOVER Study will examine clinical, environmental and socioeconomic factors in recovery from opioid use disorder (OUD) over a 24-month period following exit from a Phase III clinical program for a buprenorphine extended-release injection (RBP-6000). The study population will consist of participants from studies NCT02357901 (RB-US-13-0001) and NCT02510014 (RB-US-13-0003). The RECOVER study will characterize OUD subjects' recovery process as they transition from the controlled clinical trial environment to the real world setting.
Primary Outcome
Based on self-reported abstinence from opioids using the National Survey on Drug Use and Health (NSDUH).
Conditions Studied
Interventions
- OTHER Not applicable - no defined intervention
Study Locations (20)
Florida
- Amit Vijapura - Jacksonville
- Meridien Research - Lakeland
- Try Research - Maitland
- Innovative Clinical Research - Miami
- Scientific Clinical Research - Miami
- Research Centers of America - Oakland Park
California
- Behavioral Research Specialists - Glendale
- Collaborative Neuroscience Networks, Inc. - Long Beach
- Synergy Research Center - National City
- North County Clinical Research - Oceanside
- Artemis Institute for Clinical Research - San Diego
Alabama
- Winston Technology Research LLC - Haleyville
- Boyett Health Services - Hamilton
Louisiana
- Louisiana Research Associates - New Orleans
- Louisiana Clinical Research - Shreveport
Massachusetts
- Stanley Street Treatment and Resources - Fall River
- Adams Clinical Trials - Watertown
Arkansas
- Woodland International Research Group - Little Rock
Mississippi
- Precise Research Centers, Inc. - Flowood
Missouri
- St. Louis Clinical Trials - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 534 participants |
| Start Date | 2015-08 |
| Est. Completion | 2019-03 |
What the finished NCT03604861 record still lists
NCT03604861 is an observational study that tracks outcomes without assigning an intervention. The registered 534 participants enrollment target is mid-sized for trials with a published cap, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Not applicable - no defined intervention is the first listed.
NCT03604861 names 20 study sites across 8 states, led by Florida, California, Alabama.
Frequently Asked Questions
What is clinical trial NCT03604861 about?
NCT03604861 is a clinical study titled "An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery". The RECOVER Study will examine clinical, environmental and socioeconomic factors in recovery from opioid use disorder (OUD) over a 24-month period following exit from a Phase III clinical program for a buprenorphine extended-release injection (RBP-6000). The study population will consist of particip...
What is the current status of trial NCT03604861?
This trial is currently completed. The enrollment target is 534 participants. The study started on 2015-08. Estimated completion is 2019-03.
What conditions does trial NCT03604861 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Opioid-Related Disorders.
What interventions are being tested in trial NCT03604861?
The interventions under investigation include: Not applicable - no defined intervention (OTHER).
Who is sponsoring clinical trial NCT03604861?
This trial is sponsored by Indivior, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03604861 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Florida, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03604861's enrollment target sits among peer trials
534 32nd of 257 higher than 226 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04910685 · 534 participants · Phase 2
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
- NCT06128551 · 534 participants · Phase 1
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- NCT05614739 · 535 participants · Phase 1
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
- NCT07091617 · 535 participants · NA
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia